Skip to main content

Table 1 Descriptive analysis of the 300 included patients at baseline

From: Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study

Variables

Estimates

N

Missing information (N)

Socio-demographic factors

   Age (years), median (IQR)

40.1 (33-46.5)

 

0

   Female, % (95% CI)

70.3 (65-75)

211

0

   Body mass index (kg/m2), median (IQR)

21.8 (19.3-24.2)

 

7

HIV-related factors

   CD4 (cells/mm3), median (IQR)

325 (205-502)

 

14

   Viral load (log10 copies/ml), median (IQR)

1.65 (< 1.6-3.1)

 

11

   Current use of HAART, % (95% CI)

69.8 (65.5-75.0)

205

3

   Current use of cotrimoxazole, % (95% CI)

87 (82-90)

260

0

   History of tuberculosis, % (95% CI)

39.2 (33.7-45)

117

2

Kidney risk factors

   History of diabetes, % (95% CI)

2.0 (0.7-4.3)

6

2

   History of hypertension*, % (95% CI)

2.7 (1.1-5.2)

8

1

   Positive hepatitis B serology, % (95% CI)

5.0 (2.7-8.2)

14

19

   Positive Hepatitis C serology, % (95% CI)

5.3 (3.0-8.6)

15

20

   History of aminoglycosides use, % (95% CI)

8.7 (5.6-12.8)

23

37

   History of NSAID use, % (95% CI)

47.9 (42-54)

135

18

Renal functions

   GFR Cockroft-Gault (ml/min), median (IQR)

99.7 (79-126)

 

0

   GFR MDRD (ml/min/1.73 m2), median (IQR)

111 (88-138)

 

0

  1. IQR, Inter Quartile Range; 95% CI, 95% Confidence Interval; HAART, Highly Active Antiretroviral Therapy; NSAID, Non Steroidal Anti-Inflammatory Drugs; GFR, Glomerular Filtration Rate; MDRD, Modification of Diet in Renal Disease
  2. * TAS > 16 or TAD > 10 at physical assessment or a previous history of hypertension.